ribavirin has been researched along with silvestrol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Cai, Y; Lu, C; Makala, L; Wu, D | 1 |
| Behrendt, P; Dao Thi, VL; Engelmann, M; Friesland, M; Kinast, V; Meuleman, P; Moeller, N; Praditya, D; Sayed, IM; Steinmann, E; Todt, D; Verhoye, L | 1 |
1 review(s) available for ribavirin and silvestrol
| Article | Year |
|---|---|
Targeting translation: eIF4E as an emerging anticancer drug target.
Topics: Animals; Antineoplastic Agents; Cyclin D1; Epoxy Compounds; Eukaryotic Initiation Factor-4E; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Apoptosis Proteins; Macrolides; Neoplasms; Oligonucleotides, Antisense; Protein Biosynthesis; Ribavirin; RNA, Small Interfering; Signal Transduction; Sirolimus; Survivin; Thiazoles; Triterpenes; Vascular Endothelial Growth Factor A | 2016 |
2 other study(ies) available for ribavirin and silvestrol
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo.
Topics: Aglaia; Animals; Antiviral Agents; Cells, Cultured; Disease Models, Animal; Drug Interactions; Feces; Hepatitis E; Hepatitis E virus; Humans; Mice; Ribavirin; Triterpenes; Viral Load; Virus Replication | 2018 |